The FDA granted accelerated approval to the first cereblon E3 ligase modulation (CELMoD) therapy for relapsed or refractory multiple myeloma, the agency announced on Thursday. An oral drug, iberdomide ...
Luigi Mangione is expected to plead guilty as early as Friday in the federal case accusing him of stalking and killing UnitedHealthcare CEO Brian Thompson, according to a person familiar with the ...
President Trump's August 10 executive order on vaccines considers neither. If put into action, it would impose a burden on families in the form of additional medical visits, yet it carries no estimate ...
Suicidal ideation exists on a spectrum that includes "fleeting" off-hand comments to detailed plans of self-harm, explained David Pflaum, MD, a psychiatrist at Northwell Health Far Rockaway Treatment ...
GLP-1 agonists and bariatric surgery are top obesity treatments, raising questions of their combined efficacy. A retrospective study found that patients taking GLP-1 drugs before surgery achieved ...
The chief financial officer of a spinal implant company in Massachusetts was sentenced to 4 months in prison for paying ...
Upadacitinib dramatically improved hair regrowth for patients with severe alopecia areata in two parallel phase III randomized trials. The drug, which is under FDA review for an indication in alopecia ...
A randomized crossover trial examined the acute cardiovascular effects of inhaled cannabis among habitual users. There was a significant 9% reduction in premature heartbeats on days participants ...
The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. How much liquid is actually in pediatric vaccines? Pediatrician Nicole Baldwin, ...
HYROX is a relatively new fitness competition, created in 2017, that combines 8 km of running with performance at eight exercise stations. In this international survey of more than 400 HYROX ...
Public health experts have been quick to condemn an executive order from President Donald Trump aimed at upending childhood vaccinations in the U.S., but the biggest obstacles may be the unprecedented ...
Current guidelines recommend that focal therapy be reserved for patients with intermediate-risk prostate cancer within clinical trials or prospective registries. In a retrospective study, half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results